New venture focused on providing customized care with a personal touch
A group of seasoned, specialty pharmacy and home infusion executives, with a combined 130 years of industry experience, have announced the formation of AvevoRx, a national, independent provider of specialty infusion pharmacy services. The venture brings bespoke services and clinical care to patients facing various complex and chronic disorders who receive a range of intravenous medication therapies. AvevoRx is based out of Greensboro, North Carolina.
The AvevoRx co-founders are industry veterans of private and public companies who serve as the management team and bring deep experience in building and scaling specialty infusion therapy platforms. The company entered the market by acquiring Mid Valley Health Services, a long-established infusion company based in Modesto, Calif. Concurrent with the Mid Valley acquisition, AvevoRx opened a new pharmacy distribution center in Greensboro, N.C. The company expects to execute at least one additional acquisition before the year’s end.
“In building AvevoRx, we are investing in a future that prioritizes a patient’s most basic, fundamental needs – a welcoming human voice on the other end of the phone, a single point of contact for care navigation – and making that a part of their customized care plan,” said Robin Johnson, Co-founder and Chief Financial Officer of AvevoRx.
“The addition of Mid Valley Health Services to the AvevoRx family reinforces the core tenants of our specialized, personal care model by bringing in an amazing group of accomplished professionals in the California market,” said Lauren Pumphrey, Co-founder, and head of western-U.S. sales. “With a track record of more than 25 years of regional excellence, AvevoRx has the right foundation upon which to build.”
“Specialty infusion pharmacies are not always special, so we have set out to change that,” said Courtney Remley, Co-Founder, and head of eastern-U.S. sales. “AvevoRx is committed to remaining an independent provider that earns its reputation for scrappy, hard work and going the extra mile for patients.”
The founding management team for AvevoRx includes:
Eric Hill, Co-Founder, brings more than 30 years of specialty infusion experience to AvevoRx. Eric is the former Chief Operating Officer of Diplomat Specialty Infusion Group, which he came to via the acquisition of BioRx, the company he co-founded in 2004. The company would enjoy organic and acquisition-driven growth to become a leading specialty infusion platform with more than 800 employees, $1 billion in revenue, and approximately $100mm in EBITDA. Prior, Eric served in various Vice President roles for Coram Healthcare over a 10-year period, where as VP of Blood Products he grew the business from $30mm to $175mm in just a few years. Eric earned his Bachelor of Arts degree in Psychology from Wake Forest University in Winston-Salem, North Carolina. He splits his time between N.C and Florida.
Phil Rielly, Co-Founder, served as President of Diplomat Specialty Infusion Group until August 2020. He joined Diplomat Specialty Infusion Group in 2014 with the acquisition of BioRx, LLC, the company he co-founded with Eric Hill in 2004. Prior, Phil co-founded CliniCare, a respiratory equipment provider, and PRO2, a business serving the respiratory therapy market. Phil’s healthcare career began with Apria in 1992. He gained specialty pharmaceutical experience with Alpha Therapeutics and Coram, where he served as area market director for the blood products division. Phil earned his Bachelor of Arts in communications and marketing from Spring Hill College in Alabama.
Robin Johnson, CPA, Co-Founder, and Chief Financial Officer, brings 30+ years of professional, public, and private accounting experience to AvevoRx, with expertise in various healthcare and software verticals. She served as Chief Financial Officer for Diplomat Specialty Infusion Group through June of 2020 with oversight of eleven legal entities, eight of which were acquired during her tenure, and contributed greatly to Diplomat’s position as a leading national specialty infusion platform. Prior, Robin served as Vice President and Chief Accounting Officer for VITAS Healthcare Corporation, one of the nation’s oldest and largest providers of end-of-life care. Robin became a certified public accountant through the Kentucky State Board of Accountancy and earned her MBA from Morehead State University, Kentucky.
Lauren Pumphrey, Co-Founder, and head of western-U.S. sales, brings 9 years of experience in the specialty infusion industry to AvevoRx. Most recently, she served as regional business director for mid-Atlantic and southeast markets at OptumRx (previously Diplomat Specialty Infusion Group). Prior, she served as the west coast regional sales director, overseeing $127 mm in revenue. Concurrent with her management responsibilities, Lauren personally built and grew the leading U.S. sales territory, delivering more than $33 mm in annual revenue in just over 3 years. Lauren’s strengths are in establishing and scaling up businesses in new and untapped markets, including several in rural Indiana, Missouri, and Massachusetts. She ended 2020 as the top growth performer in the U.S., along with building a full team for the western region. She was an active participant in new therapy launches as a member of the advisory board, which serves as the committee for strategy development for new products. Lauren graduated with a degree from Ball State University in business with a minor in international studies.
Courtney Remley, Co-Founder, and head of eastern-U.S. sales, brings to AvevoRx more than 17 years in the healthcare and specialty infusion services industry. Most recently, she served as a senior national account manager for the specialty infusion division at OptumRx (previously Diplomat Specialty Infusion Group). Over her 11-year tenure at OptumRx and predecessor companies, she grew her region by 1,233%, representing regional revenue of over $12 million annually. Her focus centered on the development, contracting, and implementation of a large national contract that is innovative and transformative for the industry. Before her time in specialty infusion, she served as a sales leader and manager in long-term care, acute rehabilitation, and home healthcare industries. Courtney resides in South Carolina where she serves on multiple non-profit boards and committees. Courtney is a graduate of Purdue University with a major in Audiology and Speech Sciences.
AvevoRx currently serves patients in several states and continues to grow. Visit www.AvevoRx.com to learn more or call 877-AvevoRx.
AvevoRx is a bespoke, independent provider of specialty infusion pharmacy services. The company focuses on the highest-quality, personalized care customized to patients facing various complex, chronic disorders. Treatments are made available via specialized pharmacy locations, field nurses, and additional support staff throughout the United States. AvevoRx also provides acute infusion therapies for patients with short-term therapeutic needs on a regional basis. Privately held, the company was founded in 2021 by a small group of industry veterans with a combined experience of more than 130 years. AvevoRx is headquartered in North Carolina. To learn more, visit www.AvevoRx.com or follow us on Instagram or LinkedIn.